secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2021-07-20T23:59:59+00:00
Accession:  0001493152-21-017253
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director David Diamond resigns from Oncotelic board and audit committee
-----------------------------------------------------------------------

- David Diamond resigned from the Board of Oncotelic Therapeutics on July 16, 2021, effective immediately.
- He also served on the company's audit committee prior to resignation.
- Resignation was not due to any disagreements with management or the Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315221017253/0001493152-21-017253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315221017253/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-017253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer